Radioiodine therapy of hyperthyroidism precludes thallium-201 myocardial scintigraphy

Journal Article · Sun Feb 01 04:00:00 EST 1987 · Clin. Nucl. Med.; (United States)

DOI:https://doi.org/10.1097/00003072-198702000-00005· OSTI ID:6521857

Orzel, J A; Kruyer, W B; Borchert, R D

The authors attempted to perform Tl-201 myocardial perfusion scintigraphy in a 42-year-old man 23 and 35 days after he received 9.8 mCi of oral I-131 for documented Graves' disease. Interference from primary and scattered photons from residual thyroid I-131 made Tl-201 myocardial scintigraphy technically impossible. A series of phantom and patient studies using I-131 and Tl-201 were performed, yielding guidelines for planning Tl-201 myocardial scintigraphy following radioiodine therapy.

• Research Organization: Wilford Hall USAF Medical Center, San Antonio, TX
• OSTI ID: 6521857
• Journal Information: Clin. Nucl. Med.; (United States), Journal Name: Clin. Nucl. Med.; (United States) Vol. 2; ISSN CNMED
• Country of Publication: United States
• Language: English

Related Subjects

550601* -- Medicine-- Unsealed Radionuclides in Diagnostics
550604 -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
CARDIOVASCULAR DISEASES
CARDIOVASCULAR SYSTEM
COUNTING TECHNIQUES
DAYS LIVING RADIOISOTOPES
DIAGNOSTIC TECHNIQUES
DISEASES
ELECTRON CAPTURE RADIOISOTOPES
ENDOCRINE DISEASES
HEART
HEAVY NUCLEI
HYPERTHYROIDISM
INTERFERENCE
INTERMEDIATE MASS NUCLEI
IODINE 131
IODINE ISOTOPES
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
MEDICINE
MOCKUP
MYOCARDIAL INFARCTION
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ORGANS
PATIENTS
PHANTOMS
RADIOISOTOPE SCANNING
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
RECOMMENDATIONS
RESPONSE MODIFYING FACTORS
SCINTISCANNING
SECONDS LIVING RADIOISOTOPES
STRUCTURAL MODELS
THALLIUM 201
THALLIUM ISOTOPES
THERAPY